Christian Brizard, of the Royal Children's in Melbourne, perhaps?
http://dx.doi.org.ezp.lib.unimelb.edu.au/10.1586/17434440.2015.985651
The above 2014 article includes these statements;
Financial & competing interests disclosure
G Strange is a consultant to Admedus Regen Pty Ltd, and serves as Medical Director, Admedus Ltd. C Brizard has received honorarium for speaking for Admedus Ltd and serves on the scientific Medical advisory Board for Admedus Ltd. TR Karl has received travel grants and honorarium for speaking and serves on the Scientific Medical Advisory Board for Admedus Ltd. L Neethling serves as an advisory consultant to Admedus Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
So, yes, A/Prof Brizard did receive an 'honorarium for speaking'. Not too nefarious - I believe he still likes and uses the product, and it isn't unusual to be paid a fee to attend a conference that you would have otherwise not bothered attending.
A/Prof Brizard was still presenting on Cardiocel as recently as March of this year;
http://www.ascvts2017.org/02_sci/sci02.htm?&category=Luncheon Symposium
- Forums
- ASX - By Stock
- AVR
- Approval in Japan
Approval in Japan, page-15
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $196.8M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 298 | $9.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.85 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 298 | 9.010 |
1 | 1000 | 9.000 |
1 | 200 | 8.700 |
1 | 200 | 8.500 |
2 | 200 | 8.000 |
Price($) | Vol. | No. |
---|---|---|
9.850 | 1000 | 1 |
9.910 | 231 | 2 |
10.000 | 10250 | 2 |
10.200 | 545 | 1 |
10.500 | 10000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online